French biotech startup Generare has successfully closed a €5 million seed funding round to enhance its innovative platform for drug discovery. The startup focuses on identifying natural molecules produced by microorganisms, utilizing advanced genetic engineering techniques. Generare has already uncovered over 1,000 genetic recipes, including novel compounds with antibiotic properties. Its scalable approach promises to expedite the analysis of genetic material, potentially leading to groundbreaking pharmaceutical developments. The company aims to industrialize its processes while addressing crucial antibiotic resistance challenges in the healthcare sector.